US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.310
  • -0.020-0.46%
Close Apr 24 16:00 ET
  • 4.310
  • 0.0000.00%
Post 16:05 ET
251.34MMarket Cap-13.06P/E (TTM)

Vanda Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
3.18%198.77M
17.48%53.19M
22.76%47.65M
9.59%50.47M
-24.06%47.46M
-24.27%192.64M
-29.79%45.27M
-40.58%38.82M
-28.47%46.06M
3.83%62.5M
Operating revenue
3.18%198.77M
17.48%53.19M
22.76%47.65M
9.59%50.47M
-24.06%47.46M
-24.27%192.64M
-29.79%45.27M
-40.58%38.82M
-28.47%46.06M
3.83%62.5M
Cost of revenue
-23.53%11.31M
-25.14%2.59M
-16.72%2.55M
-21.89%2.73M
-27.94%3.44M
-39.07%14.8M
-44.53%3.46M
-51.53%3.06M
-42.25%3.5M
-15.73%4.77M
Gross profit
5.41%187.46M
21.01%50.6M
26.15%45.1M
12.18%47.74M
-23.74%44.02M
-22.71%177.84M
-28.21%41.81M
-39.40%35.75M
-27.04%42.56M
5.86%57.72M
Operating expense
18.94%228.12M
24.47%60.87M
34.38%56.1M
27.44%57.89M
-4.42%53.26M
-14.29%191.8M
-5.25%48.91M
-24.22%41.75M
-17.22%45.42M
-10.41%55.72M
Selling and administrative expenses
29.70%146.41M
66.36%39.28M
51.71%37.57M
39.00%39.47M
-16.67%30.09M
-17.29%112.88M
-27.97%23.61M
-17.04%24.77M
-13.95%28.4M
-11.61%36.1M
Research and development costs
-3.11%74.43M
-18.48%19.84M
1.06%16.78M
0.08%16.66M
9.97%21.15M
-10.43%76.82M
31.89%24.34M
-33.22%16.6M
-22.54%16.65M
-8.26%19.24M
Depreciation amortization depletion
247.99%7.27M
83.84%1.75M
360.79%1.75M
363.49%1.75M
432.45%2.02M
37.86%2.09M
151.45%953K
0.26%380K
-0.26%378K
0.00%379K
-Depreciation and amortization
247.99%7.27M
83.84%1.75M
360.79%1.75M
363.49%1.75M
432.45%2.02M
37.86%2.09M
151.45%953K
0.26%380K
-0.26%378K
0.00%379K
Operating profit
-191.43%-40.66M
-44.90%-10.28M
-83.49%-11M
-253.89%-10.15M
-560.83%-9.24M
-320.45%-13.95M
-207.01%-7.09M
-253.40%-6M
-182.84%-2.87M
126.13%2M
Net non-operating interest income expense
Other net income (expense)
-12.58%17.74M
-30.39%3.78M
-19.05%4.76M
-15.19%4.63M
29.71%4.57M
308.19%20.29M
82.07%5.43M
278.30%5.88M
1,559.27%5.46M
3,256.19%3.52M
Other non- operating income (expenses)
-12.58%17.74M
-30.39%3.78M
-19.05%4.76M
-15.19%4.63M
29.71%4.57M
308.19%20.29M
82.07%5.43M
278.30%5.88M
1,559.27%5.46M
3,256.19%3.52M
Income before tax
-461.59%-22.92M
-291.15%-6.5M
-5,103.33%-6.24M
-312.81%-5.52M
-184.37%-4.66M
-43.90%6.34M
-117.28%-1.66M
-102.20%-120K
-31.61%2.59M
173.08%5.53M
Income tax
-204.99%-4.02M
-314.48%-1.59M
-257.98%-920K
-193.10%-998K
-122.76%-518K
-23.78%3.83M
-73.15%739K
-111.73%-257K
-11.84%1.07M
300.71%2.28M
Net income
-853.29%-18.9M
-104.67%-4.91M
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-60.02%2.51M
-134.98%-2.4M
-95.81%137K
-40.95%1.52M
150.58%3.25M
Net income continuous Operations
-853.29%-18.9M
-104.67%-4.91M
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-60.02%2.51M
-134.98%-2.4M
-95.81%137K
-40.95%1.52M
150.58%3.25M
Minority interest income
Net income attributable to the parent company
-853.29%-18.9M
-104.67%-4.91M
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-60.02%2.51M
-134.98%-2.4M
-95.81%137K
-40.95%1.52M
150.58%3.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-853.29%-18.9M
-104.67%-4.91M
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-60.02%2.51M
-134.98%-2.4M
-95.81%137K
-40.95%1.52M
150.58%3.25M
Basic earnings per share
-925.00%-0.33
-100.00%-0.08
-3,878.34%-0.09
-366.67%-0.08
-216.67%-0.07
-63.64%0.04
-133.33%-0.04
-96.03%0.0024
-40.00%0.03
154.55%0.06
Diluted earnings per share
-925.00%-0.33
-100.00%-0.08
-3,883.10%-0.09
-366.67%-0.08
-216.67%-0.07
-63.64%0.04
-133.33%-0.04
-96.04%0.0024
-40.00%0.03
154.55%0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 3.18%198.77M17.48%53.19M22.76%47.65M9.59%50.47M-24.06%47.46M-24.27%192.64M-29.79%45.27M-40.58%38.82M-28.47%46.06M3.83%62.5M
Operating revenue 3.18%198.77M17.48%53.19M22.76%47.65M9.59%50.47M-24.06%47.46M-24.27%192.64M-29.79%45.27M-40.58%38.82M-28.47%46.06M3.83%62.5M
Cost of revenue -23.53%11.31M-25.14%2.59M-16.72%2.55M-21.89%2.73M-27.94%3.44M-39.07%14.8M-44.53%3.46M-51.53%3.06M-42.25%3.5M-15.73%4.77M
Gross profit 5.41%187.46M21.01%50.6M26.15%45.1M12.18%47.74M-23.74%44.02M-22.71%177.84M-28.21%41.81M-39.40%35.75M-27.04%42.56M5.86%57.72M
Operating expense 18.94%228.12M24.47%60.87M34.38%56.1M27.44%57.89M-4.42%53.26M-14.29%191.8M-5.25%48.91M-24.22%41.75M-17.22%45.42M-10.41%55.72M
Selling and administrative expenses 29.70%146.41M66.36%39.28M51.71%37.57M39.00%39.47M-16.67%30.09M-17.29%112.88M-27.97%23.61M-17.04%24.77M-13.95%28.4M-11.61%36.1M
Research and development costs -3.11%74.43M-18.48%19.84M1.06%16.78M0.08%16.66M9.97%21.15M-10.43%76.82M31.89%24.34M-33.22%16.6M-22.54%16.65M-8.26%19.24M
Depreciation amortization depletion 247.99%7.27M83.84%1.75M360.79%1.75M363.49%1.75M432.45%2.02M37.86%2.09M151.45%953K0.26%380K-0.26%378K0.00%379K
-Depreciation and amortization 247.99%7.27M83.84%1.75M360.79%1.75M363.49%1.75M432.45%2.02M37.86%2.09M151.45%953K0.26%380K-0.26%378K0.00%379K
Operating profit -191.43%-40.66M-44.90%-10.28M-83.49%-11M-253.89%-10.15M-560.83%-9.24M-320.45%-13.95M-207.01%-7.09M-253.40%-6M-182.84%-2.87M126.13%2M
Net non-operating interest income expense
Other net income (expense) -12.58%17.74M-30.39%3.78M-19.05%4.76M-15.19%4.63M29.71%4.57M308.19%20.29M82.07%5.43M278.30%5.88M1,559.27%5.46M3,256.19%3.52M
Other non- operating income (expenses) -12.58%17.74M-30.39%3.78M-19.05%4.76M-15.19%4.63M29.71%4.57M308.19%20.29M82.07%5.43M278.30%5.88M1,559.27%5.46M3,256.19%3.52M
Income before tax -461.59%-22.92M-291.15%-6.5M-5,103.33%-6.24M-312.81%-5.52M-184.37%-4.66M-43.90%6.34M-117.28%-1.66M-102.20%-120K-31.61%2.59M173.08%5.53M
Income tax -204.99%-4.02M-314.48%-1.59M-257.98%-920K-193.10%-998K-122.76%-518K-23.78%3.83M-73.15%739K-111.73%-257K-11.84%1.07M300.71%2.28M
Net income -853.29%-18.9M-104.67%-4.91M-3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M-60.02%2.51M-134.98%-2.4M-95.81%137K-40.95%1.52M150.58%3.25M
Net income continuous Operations -853.29%-18.9M-104.67%-4.91M-3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M-60.02%2.51M-134.98%-2.4M-95.81%137K-40.95%1.52M150.58%3.25M
Minority interest income
Net income attributable to the parent company -853.29%-18.9M-104.67%-4.91M-3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M-60.02%2.51M-134.98%-2.4M-95.81%137K-40.95%1.52M150.58%3.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -853.29%-18.9M-104.67%-4.91M-3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M-60.02%2.51M-134.98%-2.4M-95.81%137K-40.95%1.52M150.58%3.25M
Basic earnings per share -925.00%-0.33-100.00%-0.08-3,878.34%-0.09-366.67%-0.08-216.67%-0.07-63.64%0.04-133.33%-0.04-96.03%0.0024-40.00%0.03154.55%0.06
Diluted earnings per share -925.00%-0.33-100.00%-0.08-3,883.10%-0.09-366.67%-0.08-216.67%-0.07-63.64%0.04-133.33%-0.04-96.04%0.0024-40.00%0.03154.55%0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More